ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

PARP-1 inhibition attenuates tumor pathology in a novel murine model of diabetes-associated colitis-induced colorectal cancer.

Shivani Singla et al.PubMed ↗Publisher ↗

No numbers read from the abstract.